| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240419 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 6 Pages |
Abstract
These data suggest that permanent brachytherapy dose prescriptions can be customized to risk status. In low-risk patients, achieving a BED of â¥140 Gy might be adequate for prostate-specific antigen control. However, high-risk disease might require a BED dose of â¥200 Gy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Nelson N. M.D., Louis M.D., Brian J. M.D., Ph.D., Jay P. M.D., Michael J. M.D., Mack M.D., Paul A. B.A., Michael W. Ph.D., Richard G. M.D.,